Browse diseases

…les (HR: 0.86, 95% CI: 0.75 to 0.99, p=0.035) exhibited reduced CKD risks, with no significant interaction between the sexes (p for…

…mportance of managing IR and metabolic comorbidities to prevent CKD onset in at-risk populations.…

…annotated for the significant loci after Bonferroni correction. CKD, chronic kidney disease; CKD-EPI, Chronic Kidney Disease Epidem…

…CKD ( table 1).Table 1Baseline characteristics of patients with T2DM and hypertension stratified by FIB-4 indexTotal (n=1208)FIB-4 ≤…

…r associated risk of CV events among those testing positive for COVID-19.…

…s, resulted in greater specificity in identifying patients with type 2 diabetes than studies that rely on diagnosis codes alone. By identifying…

…st that when sulfonylureas must be used for glucose-lowering in T2D, clinicians may want to avoid glipizide and prioritize glimepir…

…n/1.73 m2, p<0.0001), associated with a more complex history of cirrhosis complications, with ascites occurring in 76.5% of CKD+ versus 6…

…nt, 74 patients (34.3%) had no evidence of CKD, 105 (49.5%) had CKD stage 3a, 24 (11.1%) stage 3b, 10 (4.6%) stage 4, and 3 (1.4%) …

…afety of immune checkpoint inhibitors in patients with advanced chronic kidney disease. Oncologist. 2023;28(6):e379–e386. doi:10.1093/oncolo/oyad066…

…respectively; all p<0.001).Conclusions In patients with CKD and type 2 diabetes, a >30% UACR decrease was associated with lower risk of mortali…

…robiota has been linked to non-communicable diseases, including chronic kidney disease (CKD). However, the relationships between gut microbiome compos…